“Agni-5 missile is capable of carrying a nuclear warhead of about 1.5 tonnes.”
NEW DELHI: On Sunday, India, successfully test-fired its indigenously developed nuclear capable long range ballistic missile Agni-5, having a strike range of 5,000 km from Dr Abdul Kalam Island off the Odisha coast.
It was the sixth trial of the state-of-the-art Agni-5. The defence officials confirmed that, the surface-to-surface missile was launched with the help of a mobile launcher from launch pad-4 of the Integrated Test Range (ITR) at Dr Abdul Kalam Island in the Bay of Bengal at 9.48 am.
“The flight performance of the missile was tracked and monitored by radars, tracking instruments and observation stations all through the mission. The high speed on-board computer and fault-tolerant software along with robust and reliable bus guided the Missile flawlessly,” the sources said.
‘Hitting the intended target with a high speed’
The officials of the Defence Research and Development Organisation( DRDO ) has explained that the Agni-5 is different from other missile of the series, as it has been advanced with new technologies in terms of navigation and guidance, warhead and engine.
The missile has been programmed in a way that upon reaching the peak of its trajectory, it will turn towards the earth and continue its journey towards the intended target with an increased speed due to the attraction of earth’s gravitational pull. The path has been precisely directed by the advanced on-board computer and inertial navigation system, which helps the missile to hit it designated target point more accurately.
Moreover, the three-stage, 17-metre tall, two-metre wide Agni-5 missile is capable of carrying a nuclear warhead of about 1.5 tonnes.
‘All the earlier trials were successful’
At present, apart from the Agni-5, other Agni missiles that India has in its armoury are: Agni-1 with a 700-km range, Agni-2 with a 2,000-km range, Agni-3 and Agni-4 with 2,500 km to more than 3,500 km range.
The first test of Agni-5 was conducted on April 19, 2012, the second on September 15, 2013, the third on January 31, 2015 and fourth on December 26, 2016. The last test was held on January 18, 2018 and all these earlier trials were successful.